ERBB2 and breast carcinoma: By using cathepsins and HER2+ and HER2- carcinomas in the breast as outcomes, we aimed to elucidate the potential mechanisms of the impact of gene expression on the risk of breast cancer, particularly through the regulation of cathepsin expression levels.